Saliva testing for ketamine can detect the parent compound for approximately 24–48 hours after use. However, saliva-based ketamine testing is rare — even less common than urine testing. Standard oral fluid drug panels focus on cannabis, cocaine, opiates, amphetamines, and PCP. Ketamine would only be detected by a specifically ordered expanded panel or specialized forensic analysis.
Ketamine enters saliva primarily through passive diffusion from blood. Because ketamine is a weak base (pKa 7.5), oral fluid concentrations are influenced by local pH conditions in the mouth. After insufflation, residual ketamine in nasal passages can drain into the oral cavity and temporarily elevate saliva concentrations independent of blood levels.
The detection window for saliva is shorter than urine because saliva reflects free circulating drug levels rather than accumulated metabolites. Once blood ketamine drops below detectable levels (typically within 10–20 hours), saliva concentrations follow. The norketamine metabolite is present in saliva but at lower concentrations than the parent compound.
Oral fluid collection devices used in commercial testing are designed for the standard panel substances. Ketamine-specific oral fluid testing requires specialized laboratory analysis (LC-MS/MS) and is typically performed only in research settings, forensic investigations, or specialized monitoring programs. The practical likelihood of encountering a saliva test that screens for ketamine is very low.
Standard roadside oral fluid panels do not include ketamine. They typically screen for cannabis, cocaine, opiates, amphetamines, and sometimes PCP or benzodiazepines.
Laboratory-based LC-MS/MS saliva analysis is accurate but rarely performed. Point-of-care oral fluid devices are not designed to detect ketamine and will not produce a positive result regardless of ketamine use.